BioRestorative Therapies, Inc.
BRTX
$1.09
$0.010.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -96.11% | 1,113.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -96.11% | 1,113.20% | |||
| Cost of Revenue | 21.84% | 200.00% | |||
| Gross Profit | -99.59% | 1,233.03% | |||
| SG&A Expenses | -18.81% | -55.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.11% | -25.33% | |||
| Operating Income | -12.21% | 31.25% | |||
| Income Before Tax | -14.38% | 50.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -14.38% | 50.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.38% | 50.25% | |||
| EBIT | -12.21% | 31.25% | |||
| EBITDA | -12.42% | 31.61% | |||
| EPS Basic | -9.67% | 52.44% | |||
| Normalized Basic EPS | -9.69% | 52.44% | |||
| EPS Diluted | -9.67% | 52.44% | |||
| Normalized Diluted EPS | -9.69% | 52.44% | |||
| Average Basic Shares Outstanding | 4.30% | 4.59% | |||
| Average Diluted Shares Outstanding | 4.30% | 4.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||